<DOC>
	<DOCNO>NCT02183623</DOCNO>
	<brief_summary>Investigation multiple dose pharmacokinetics , safety tolerability simvastatin simvastatin acid without concomitant administration BI 1356 BS</brief_summary>
	<brief_title>The Effect Multiple Oral Doses BI 1356 BS Pharmacokinetics , Safety Tolerability Multiple Oral Doses Simvastatin Pharmacokinetics Its Metabolite Simvastatin Acid Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Linagliptin</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Healthy male subject accord follow criterion : No finding deviate normal clinical relevance well evidence clinically relevant concomitant disease base upon complete medical history , include physical examination , vital sign ( Blood Pressure ( BP ) , Pulse Rate ( PR ) ) , 12lead Electrocardiogram ( ECG ) , clinical laboratory test Age ≥21 Age ≤65 year BMI ≥18.5 BMI ≤29.9 kg/m2 ( Body Mass Index ) Signed date write informed consent prior admission study accordance Good Clinical Practice ( GCP ) local legislation Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Surgery gastrointestinal tract ( except appendectomy ) Diseases central nervous system ( epilepsy ) psychiatric disorder orneurological disorder History relevant orthostatic hypotension , faint spell blackouts Chronic relevant acute infection History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator Intake drug long halflife ( &gt; 24 hour ) within least one month le 10 halflives respective drug prior administration trial Use drug , include herbal product , might reasonably influence result trial base knowledge time protocol preparation within 10 day prior administration trial Participation another trial investigational drug within two month prior administration trial Smoker ( &gt; 10 cigarette &gt; 3 cigar &gt; 3 pipes/day ) Inability refrain smoke trial day Alcohol abuse ( 60 g/day ) Drug abuse Blood donation ( 100 mL within four week prior administration trial ) Excessive physical activity ( within one week prior administration trial ) Any laboratory value outside reference range clinical relevance Inability comply dietary regimen study centre Not willing use adequate contraception ( condom use plus another form contraception e.g . spermicide , oral contraceptive take female partner , sterilisation , intrauterine device ) whole study period time first intake study drug one month last intake</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>